Innoviva Analyst Ratings
Innoviva Analyst Ratings
While ratings are subjective and will change, the latest Innoviva (INVA) rating was a maintained with a price target of $13.00 to $14.00. The current price Innoviva (INVA) is trading at is $12.95, which is out of the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/13/2022 | 8.11% | Morgan Stanley | $13 → $14 | Maintains | Underweight |
| 08/08/2022 | 0.39% | Morgan Stanley | $12 → $13 | Maintains | Underweight |
| 07/20/2022 | 23.55% | Goldman Sachs | → $16 | Initiates Coverage On | → Neutral |
| 07/15/2022 | -7.34% | Morgan Stanley | $13 → $12 | Maintains | Underweight |
| 04/12/2022 | 0.39% | Morgan Stanley | $12 → $13 | Maintains | Underweight |
| 02/23/2022 | -7.34% | Morgan Stanley | $10 → $12 | Maintains | Underweight |
| 02/11/2022 | 116.22% | EF Hutton | → $28 | Initiates Coverage On | → Buy |
| 11/11/2020 | -22.78% | Morgan Stanley | $8 → $10 | Maintains | Underweight |
| 06/25/2018 | — | Stifel | Terminates Coverage On | Hold → Hold | |
| 04/27/2018 | 23.55% | Stifel | $17 → $16 | Maintains | Hold |
| 11/20/2017 | 0.39% | Deutsche Bank | → $13 | Initiates Coverage On | → Hold |
| 日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变动 | 之前/当前的评级 |
|---|---|---|---|---|---|
| 2022 年 10 月 13 日 | 8.11% | 摩根士丹利 | 13 美元 → 14 美元 | 维护 | 体重不足 |
| 08/08/2022 | 0.39% | 摩根士丹利 | 12 美元 → 13 美元 | 维护 | 体重不足 |
| 07/20/2022 | 23.55% | 高盛 | → 16 美元 | 启动覆盖范围开启 | → 中立 |
| 07/15/2022 | -7.34% | 摩根士丹利 | 13 美元 → 12 美元 | 维护 | 体重不足 |
| 04/12/2022 | 0.39% | 摩根士丹利 | 12 美元 → 13 美元 | 维护 | 体重不足 |
| 2022 年 2 月 23 日 | -7.34% | 摩根士丹利 | 10 美元 → 12 美元 | 维护 | 体重不足 |
| 2022 年 11 月 2 日 | 116.22% | EF Hutton | → 28 美元 | 启动覆盖范围开启 | → 购买 |
| 11/11/2020 | -22.78% | 摩根士丹利 | 8 美元 → 10 美元 | 维护 | 体重不足 |
| 2018 年 6 月 25 日 | — | Stifel | 终止承保范围 | 按住 → 按住 | |
| 04/27/2018 | 23.55% | Stifel | 17 美元 → 16 美元 | 维护 | 保持 |
| 11/20/2017 | 0.39% | 德意志银行 | → 13 美元 | 启动覆盖范围开启 | → 按住 |
Innoviva Questions & Answers
Innoviva 问题与解答
The latest price target for Innoviva (NASDAQ: INVA) was reported by Morgan Stanley on October 13, 2022. The analyst firm set a price target for $14.00 expecting INVA to rise to within 12 months (a possible 8.11% upside). 7 analyst firms have reported ratings in the last year.
摩根士丹利于2022年10月13日公布了Innoviva（纳斯达克股票代码：INVA）的最新目标股价。该分析公司将目标股价定为14.00美元，预计INVA将在12个月内升至12个月内（可能上涨8.11％）。去年有7家分析公司公布了评级。
The latest analyst rating for Innoviva (NASDAQ: INVA) was provided by Morgan Stanley, and Innoviva maintained their underweight rating.
摩根士丹利对Innoviva（纳斯达克股票代码：INVA）的最新分析师评级由摩根士丹利提供，Innoviva维持其减持评级。
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Innoviva, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Innoviva was filed on October 13, 2022 so you should expect the next rating to be made available sometime around October 13, 2023.
分析师在进行了广泛的研究后得出了股票评级，其中包括浏览公开财务报表，与Innoviva的高管和客户交谈，以及听取财报电话会议。大多数分析师每三个月做一次这样的评级，因此每家公司每年应该获得4次评级。Innoviva的最新评级是在2022年10月13日发布的，因此您应该预计下一个评级将在2023年10月13日左右公布。
While ratings are subjective and will change, the latest Innoviva (INVA) rating was a maintained with a price target of $13.00 to $14.00. The current price Innoviva (INVA) is trading at is $12.95, which is out of the analyst's predicted range.
尽管评级是主观的，并且会发生变化，但最新的Innoviva（INVA）评级保持不变，目标股价为13.00美元至14.00美元。Innoviva（INVA）目前的交易价格为12.95美元，超出了分析师的预期区间。
